Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia

scientific article published on 20 December 2018

Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41375-018-0302-Y
P932PMC publication ID6756078
P698PubMed publication ID30573777

P50authorGuido KobbeQ94590887
Arnold GanserQ99412936
Jürgen FinkeQ114426803
Silke HeidenreichQ114426811
Arne BrechtQ114426819
Linda KosterQ114426824
Per LjungmanQ52717443
Liisa VolinQ53381572
Ibrahim Yakoub-AghaQ58191171
Thomas LuftQ59562402
Uwe PlatzbeckerQ71792160
Liesbeth De WreedeQ82675560
Nicolaus KrögerQ86950236
Johannes ScheteligQ87777753
Matthias StelljesQ87844970
Dietger NiederwieserQ88402151
Michel van GelderQ88901058
Dietrich W BeelenQ89402080
Johan MaertensQ89490552
P2093author name stringGerard Socié
Marie Robin
Arnon Nagler
Antonin Vitek
G J Mufti
P2860cites workAllogeneic stem cell transplantation for elderly patients with myelodysplastic syndromeQ27028159
Secondary solid cancer screening following hematopoietic cell transplantationQ28088369
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group ReportQ30245682
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized dataQ30675919
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantationQ33615619
Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantationQ33710708
Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndromeQ33813439
Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phaseQ33813443
Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients.Q33978945
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantationQ34260505
Reduced mortality after allogeneic hematopoietic-cell transplantationQ34472861
Long-term survival and late deaths after allogeneic hematopoietic cell transplantationQ35023409
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor StudyQ36141716
Analysing population-based cancer survival - settling the controversiesQ36212210
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation.Q36219840
Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow TransplantationQ38086718
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term OutcomesQ38374821
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panelQ39092515
Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT.Q39308114
Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic SyndromesQ40276791
Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioningQ40282393
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in MyeloQ44295238
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesQ46389618
How I monitor long-term and late effects after blood or marrow transplantationQ47571887
Cancer Survivorship Care in Advanced Primary Care Practices: A Qualitative Study of Challenges and OpportunitiesQ47874534
Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer: An Initial Report From the Surveillance, Epidemiology, and End Results ProgramQ49722439
The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models.Q51714177
Quantification of the completeness of follow-up.Q52938972
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell TransplantQ57052529
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant RegistryQ77941016
Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemiaQ82236404
Relative survival analysis in RQ82697345
Risk and timing of cardiovascular death among patients with myelodysplastic syndromesQ89777441
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectleukemiaQ29496
acute myeloid leukemiaQ264118
P1104number of pages10
P304page(s)686-695
P577publication date2018-12-20
P1433published inLeukemiaQ6534498
P1476titleLate treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia
P478volume33

Reverse relations

Q64116751Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosiscites workP2860

Search more.